key: cord-0996047-ybowq9u7
authors: Berto, Martina Boscolo; Spano, Giancarlo; Wagner, Benedikt; Bernhard, Benedikt; Häner, Jonas; Huber, Adrian T.; Gräni, Christoph
title: Takotsubo Cardiomyopathy After mRNA COVID-19 Vaccination
date: 2021-07-15
journal: Heart Lung Circ
DOI: 10.1016/j.hlc.2021.06.521
sha: bf35325893e2516b21285f4c174bb9bc6550ebe2
doc_id: 996047
cord_uid: ybowq9u7

nan

A healthy 63-year-old woman with no cardiovascular risk factors was admitted to the emergency room with new-onset dyspnoea and fever. The symptoms started 1 day after receiving the first of two mRNA-1273 (Moderna, Cambridge, MA, USA) COVID-19

vaccinations. She had no other prior complaints. A retronasal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test was negative. Laboratory tests revealed normal results for creatinine, creatine kinase, and creatine kinase MB (myocardial type). Highsensitivity troponin T was elevated at 320 ng/L (normal: <14 ng/L), and N-terminal pro-B-type natriuretic peptide was highly elevated at 10,180 pg/mL (normal: <284 pg/mL). C-reactive protein was elevated, but the leucocytes were within the normal range at 8.44 g/L (reference interval [RI]: 3.00-10.5 g/L). Urine and blood cultures were negative. Computed tomography scan of the chest revealed no pulmonary embolism but did show signs of heart failure. An electrocardiogram showed negative T waves over the inferior/anterior leads. Invasive coronary angiography ruled out coronary artery disease, but the ventriculogram (Figure) showed midventricular to apical ballooning (asterisk) with preserved basal contraction (blues arrows) and a moderately impaired left ventricular ejection fraction of 40%. Apical ballooning was confirmed by echocardiography and cardiac magnetic resonance imaging (CMR). Cardiac magnetic resonance imaging tissue characterisation further depicted extensive oedema in the mid-ventricular/apical segments (i.e., T2-weighted imaging in the myocardium vs skeletal muscle with a signal intensity ratio of >2.0), elevated T2 mapping at 56 ms (RI 42-50 ms), elevated T1 mapping at 1,158 ms (RI: 903-1059 ms), and the extracellular volume fraction was elevated at 35% (RI: 25±4%). There was no late gadolinium enhancement suggesting peri-/myocarditis and no pleural or pericardial effusion. As there were no other underlying stressors for the mid-ventricular/apical oedema and ballooning, the most probable diagnosis of COVID-19 vaccine-induced Takotsubo cardiomyopathy (TCM) was made. Although myocarditis is a possible differential diagnosis after COVID-19 vaccination [1] , the clinical and investigative features of this case were strongly suggestive of TCM. There have been rare reports of TCM after influenza vaccination [2, 3] , with an underlying pathophysiology of systemic inflammatory stress reaction after vaccination with a sympathovagal imbalance towards adrenergic predominance [4] . Takotsubo cardiomyopathy confirmed by CMR after a COVID-19 vaccination has not yet been reported and may be considered as a differential diagnosis besides myocarditis in this clinical setting.

Myocarditis following COVID-19 mRNA vaccination

Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system

Tako-Tsubo cardiomyopathy after influenza vaccination

Inflammationrelated effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function